跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 832 条关于
“Sigma-1R”
全部
832
临床试验
423
药物
224
机构
13
资讯
172
2个月前
Tardive Dyskinesia Market Projected to Reach USD 4.4 Billion by 2036, Growing at 8.1% CAGR Amid Pipeline Innovation
去年
Imugene's Azer-Cel Trial Opens First Australian Site; Neuren's Daybue Sales Exceed Expectations
9个月前
Tonix Pharmaceuticals Licenses TNX-4900, Novel Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain
去年
Oral GLP-1R Obesity Drugs Race to Market as Novo Nordisk and Eli Lilly Lead Phase III Trials
去年
Novel GCGR/GLP-1R Dual Agonist TB001 Shows Promise for Treating Kidney Fibrosis
去年
China Approves SYCUME®: First IGF-1R Antibody for Thyroid Eye Disease in 70 Years
去年
Biocytogen and Nanjing Chia Tai Tianqing Receive IND Approval for Second-Generation Anti-IGF-1R Antibody NTB003 in Thyroid Eye Disease
去年
Ascletis' Oral GLP-1RA ASC30 Shows Promising Results in Obesity Trials
上个月
Khartis Therapeutics Emerges from Stealth with $95 Million to Advance First Oral, Selective IGF-1R Inhibitor for Thyroid Eye Disease
2年前
Innovent's Mazdutide Achieves Phase 3 Success in Chinese Obesity Trial, Paving Way for First GLP-1R/GCGR Dual Agonist Approval
第 1 页,共 18 页
上一页
下一页